公司资料
ATAI Life Sciences 股价、新闻与催化剂
- 股票代码:
- ATAI
- 交易所:
- NASDAQ
- 行业:
- Life Science Tools
- 所在地:
- Germany with U
股票表现
7.24 USD (-0.28%)
收盘价
最后更新: 2026年8月17日
1.77B USD
市值
股价为何变动
As of Aug 17, 2026, ATAI closed down 0.28% at $7.24. No new same-company headline was identified in the current news window.
公司概览
业务概览
atai Life Sciences is a mental-health company building a portfolio around psychedelic and novel neuropsychiatric therapies. Its story is centered on the possibility of new treatment paradigms for depression and related disorders.
所在地与行业分类
Headquartered in Germany with U.S. market exposure and listed on NASDAQ as an ADR, atai has a global mental-health biotech profile.
商业模式特征
The company depends on clinical data, regulatory progress, and the commercial viability of novel psychiatric treatments.
生物医药行业定位
atai is a high-catalyst CNS name with strong sensitivity to clinical and regulatory outcomes.
未来催化剂
- ATAI’s key catalysts are BPL-003 and VLS-01, the psychedelic-therapy assets that define the company’s next chapter. The stock will move if the clinical path keeps looking more practical and less experimental.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。